🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
PF-06651600 is being developed for treatment of inflammatory bowel disease....
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2016-02
Trial ID
NCT02684760
Treatments Being Tested
GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is und...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00536497
Treatments Being Tested
a study to investigate the pharmacokinetic characteristics and safety/toler...
Status
Unknown
Location
Gachon University Gil Medical Center
Start Date
2019-04-01
Trial ID
NCT03920579
Treatments Being Tested
This study involves 2 parts, Part A and Part B. The purpose of Part A is to...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-09
Trial ID
NCT01681186
Treatments Being Tested
The main aims of the study are to check for side effects from teduglutide. ...
Status
Completed
Location
University of Tsukuba Hospital
Start Date
2022-01-04
Trial ID
NCT05027308
Treatments Being Tested
Primary Objective: To evaluate for each influenza strain the non-inferiori...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00391391
The purpose of this placebo controlled study is to evaluate the safety and ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-09-25
Trial ID
NCT01949090
Treatments Being Tested
ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-05-08
Trial ID
NCT04401579
Treatments Being Tested
This study is a first-in-man study that will investigate the safety, tolera...
Status
Completed
Location
CRS Clinical Research Services Berlin GmbH
Start Date
2017-07-18
Trial ID
NCT03212586
Treatments Being Tested